Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 CAD | 0.00% | 0.00% | +5.88% |
Apr. 09 | Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting | MT |
2023 | Rakovina Therapeutics Announces Appointment to Scientific Advisory Board | MT |
Sales 2021 | - | Sales 2022 | - | Capitalization | 12.57M 17.22M |
---|---|---|---|---|---|
Net income 2021 | -5M -6.85M | Net income 2022 | -2M -2.74M | EV / Sales 2021 | - |
Net cash position 2021 | 2.81 3.85 | Net cash position 2022 | 0.9 1.23 | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.14
x | P/E ratio 2022 |
-4.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 54.28% |
Current month | -10.00% | ||
1 month | +20.00% | ||
3 months | -10.00% | ||
6 months | -5.26% | ||
Current year | +5.88% |
Managers | Title | Age | Since |
---|---|---|---|
Mads Daugaard
PSD | President | - | 20-12-31 |
David Hyman
DFI | Director of Finance/CFO | - | - |
John Langlands
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 19-05-05 | |
Jeffrey Bacha
CHM | Chairman | 56 | 20-11-30 |
Dennis Brown
BRD | Director/Board Member | 74 | 21-03-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.09 | 0.00% | 40,000 |
24-04-19 | 0.09 | -5.26% | 30,000 |
24-04-18 | 0.095 | +5.56% | 30,000 |
24-04-17 | 0.09 | -5.26% | 55,000 |
24-04-16 | 0.095 | +5.56% | 61,000 |
Delayed Quote Toronto S.E., April 22, 2024 at 03:42 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+5.88% | 4.6M | |
+2.49% | 96.73B | |
-0.61% | 21.31B | |
-16.61% | 21.21B | |
-5.24% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |
- Stock Market
- Equities
- RKV Stock